Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
34%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
XLV
60
HOLDINGS
12%
ALSO IN THNR
THNR
18
HOLDINGS
39%
ALSO IN XLV
SECTOR DRIFT (XLV minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.9% | 12.2% | 12.2% |
|
ABBVIE INC | 7.8% | 5.8% | 5.8% |
|
MERCK & CO. INC. | 5.5% | 5.2% | 5.2% |
|
AMGEN INC | 3.8% | 6.3% | 3.8% |
|
GILEAD SCIENCES INC | 3.2% | 5.9% | 3.2% |
XLV Overweight Relative to THNR
|
JOHNSON & JOHNSON | 9.8% |
|
UNITEDHEALTH GROUP INC | 5.4% |
|
ELI LILLY & CO | 4.7% |
|
THERMO FISHER SCIENTIFIC INC | 3.8% |
|
ABBOTT LABORATORIES | 2.7% |
|
INTUITIVE SURGICAL INC | 2.3% |
|
DANAHER CORP | 2.2% |
|
VERTEX PHARMACEUTICALS INC | 2.1% |
|
ABBVIE INC | 1.9% |
|
BRISTOL-MYERS SQUIBB CO | 1.9% |
XLV Underweight Relative to THNR
 |
NOVO-NORDISK A/S-SPONS ADR | -8.8% |
 |
ASTRAZENECA PLC | -6.1% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -5.1% |
|
REGENERON PHARMACEUTICALS | -4.7% |
 |
CHINA PHARMACEUTICAL GROUP | -4.5% |
 |
INNOVENT BIOLOGICS, INC. | -4.3% |
|
VIKING THERAPEUTICS, INC. | -4.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.6% |
|
ZEALAND PHARMA A/S | -3.5% |
|
PFIZER INC | -3.1% |